Arnold & Porter·FDA-LIFE-SCIENCES-REGULATORY

China expands life sciences enforcement with stricter bribery thresholds

China's regulators lowered criminal liability thresholds for healthcare bribery while increasing unannounced inspections and enforcement actions against life sciences companies.

china-compliancelife-sciences-enforcementanti-corruptionhealthcare-briberymedical-data-securityregulatory-compliance
Read the original firm alert →Thursday, August 6, 2026

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.